Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

RxSight (RXST) Cost of Revenue (2020 - 2026)

RxSight filings provide 6 years of Cost of Revenue readings, the most recent being $7.3 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 35.72% to $7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $31.5 million, a 23.21% decrease, with the full-year FY2025 number at $31.5 million, down 23.21% from a year prior.
  • Cost of Revenue hit $7.3 million in Q4 2025 for RxSight, up from $6.1 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $11.4 million in Q4 2024 to a low of $2.4 million in Q1 2021.
  • Median Cost of Revenue over the past 5 years was $7.9 million (2025), compared with a mean of $7.7 million.
  • Biggest five-year swings in Cost of Revenue: soared 119.07% in 2022 and later crashed 39.44% in 2025.
  • RxSight's Cost of Revenue stood at $5.6 million in 2021, then skyrocketed by 55.95% to $8.7 million in 2022, then rose by 26.08% to $10.9 million in 2023, then increased by 4.58% to $11.4 million in 2024, then crashed by 35.72% to $7.3 million in 2025.
  • The last three reported values for Cost of Revenue were $7.3 million (Q4 2025), $6.1 million (Q3 2025), and $8.4 million (Q2 2025) per Business Quant data.